Trial intelligence / Profile preview

Fenoterol vs DSCG MDI in Bronchial Asthma

NCT02177370Phase 3Terminated

Sponsor
Boehringer Ingelheim
Start
Feb 1990
Primary completion
Oct 1996
Modality
Small Molecules
01

Overview

A Phase 3 trial of fenoterol in asthma, sponsored by Boehringer Ingelheim. Started Feb 1990; status: terminated.

02

Drugs

fenoterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT02177370.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02177370.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call